New Treatment for a Type of Late Stage Prostate Cancer has Been Approved by FDA
U.S. Food and Drug Administration has approved Xtandi (enzalutamide) to treat men suffering from late-stage (metastatic) castration-resistant prostate cancer that has spread or recurred, even with...
View ArticleNew Prostate Cancer Test Could Reduce Repeat Biopsies
A new gene based prostate cancer test could reduce the chances of painful repeat biopsies that can cause some serious infections as shown by latest research to be published in the November issue of the...
View ArticleCompound in Grapes, Red Wine a “New Weapon” for Prostate Cancer
All types of prostate cancers including aggressive tumor could be effectively treated be using certain compounds present in grape skins and red wine, according to the latest research published in the...
View ArticleResearchers Find Avian Virus can be Dangerous to Cancer Cells
A study at the Virginia-Maryland Regional College of Veterinary Medicine has identified a chicken-killing virus to be a promising treatment for cancer of prostate in humans. Scientific study has...
View ArticleScientists Identified First Genetic Factor in Prostate Cancer Prognosis
CNIO researchers, together with scientists in the United Kingdom, have revealed that hereditary mutations in the BRCA2 gene predispose patients to a worse evolution of the illness and a greater risk of...
View ArticleSpecificity may be Increased by Personalizing Prostate Specific Antigen...
Researchers have already identified some genetic variants that could increase the risk of prostate cancer due to the presence of higher level of serum prostate specific antigen (PSA). So if these...
View ArticleRisk of Prostate Cancer is Higher in Men with Sleep Problems
Risk of prostate cancer is two times higher in men with sleep problems according to the latest study published in the journal of Cancer Epidemiology, Biomarkers & Prevention, a journal of the...
View ArticleXofigo Approved by FDA for Advanced Prostate Cancer
The U.S. Food and Drug Administration has approved a new advanced drug Xofigo (radium Ra 223 dichloride) for the treatment of symptomatic late-stage (metastatic) castration-resistant prostate cancer...
View ArticleAbraxane Gets FDA Approval To Treat Metastatic Pancreatic Cancer
Patients suffering from metastatic pancreatic cancer can be treated by using Abraxane (paclitaxel protein-bound particles for injectable suspension, albumin-bound) after the approval of U.S. Food and...
View ArticleMedication Does Not Help Prevent Erectile Dysfunction Following Radiation...
Bottom Line: Among men undergoing radiation therapy for prostate cancer, daily use of the erectile dysfunction drug tadalafil, compared with placebo, did not prevent loss of erectile function,...
View Article
More Pages to Explore .....